In this engaging discussion, Dr. Natalie Callender and Dr. Tom Martin, renowned experts in hematologic oncology, tackle the intricacies of multiple myeloma treatment. They delve into unique challenges for elderly patients, highlighting key findings from the AQUILA trial that enhance treatment strategies. The episode also explores the promising role of Selenexer and advances in CAR T-cell therapies, bringing light to the complexities of neurotoxicity and emerging therapies. The conversation emphasizes personalized treatment approaches for better outcomes in diverse patient demographics.
